tannin < target < targeted

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by target

Number of relevant bibliographic references: 14.

Ident.	Authors (with country if any)	Title
000111 (2021)	L. Ratiani ; S. Gegechkory ; K. Machavariani ; T. Shotadze ; T. Sanikidze [Géorgie (pays)] ; N. Intskirveli	THE PECULIARITY OF COVID- 19 GENOME AND THE CORONAVIRUS RNA TRANSLATION PROCESS AS APOTENTIAL TARGET FOR ETIOTROPIC MEDICATIONSWITH ADENINE AND OTHER NUCLEOTIDE ANALOGUES (REVIEW).
000395 (2021)	Suresh Kumar [Inde] ; Priya Kashyap [Inde] ; Suman Chowdhury [Inde] ; Shivani Kumar [Inde] ; Anil Panwar [Inde] ; Ashok Kumar [Inde]	Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication.
000592 (2021)	Hasan Çubuk ; Mehmet Özb L	Comparison of clinically approved molecules on SARS-CoV-2 drug target proteins: a molecular docking study.
000B54 (2020)	Tyler C. Beck [États-Unis] ; Kyle R. Beck [États-Unis] ; Calvin B. Holloway [États-Unis] ; Richard A. Hemings [États-Unis] ; Thomas A. Dix [États-Unis] ; Russell A. Norris [États-Unis]	The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine.
000B67 (2020)	Jiayu Liao [États-Unis] ; George Way [États-Unis] ; Vipul Madahar [États-Unis]	Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenza virus therapies.
000E12 (2020)	Usman Arshad [Royaume-Uni] ; Henry Pertinez [Royaume-Uni] ; Helen Box [Royaume-Uni] ; Lee Tatham [Royaume-Uni] ; Rajith K R. Rajoli [Royaume-Uni] ; Paul Curley [Royaume-Uni] ; Megan Neary [Royaume-Uni] ; Joanne Sharp [Royaume-Uni] ; Neill J. Liptrott [Royaume-Uni] ; Anthony Valentijn [Royaume-Uni] ; Christopher David [Royaume-Uni] ; Steve P. Rannard [Royaume-Uni] ; Paul M. O'Neill [Royaume-Uni] ; Ghaith Aljayyoussi [Royaume-Uni] ; Shaun H. Pennington [Royaume-Uni] ; Stephen A. Ward [Royaume-Uni] ; Andrew Hill [Royaume-Uni] ; David J. Back [Royaume-Uni] ; Saye H. Khoo [Royaume-Uni] ; Patrick G. Bray [Royaume-Uni] ; Giancarlo A. Biagini [Royaume-Uni] ; Andrew Owen [Royaume-Uni]	Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.
000F10 (2020)	Allan Sauvat [France] ; Fabiola Ciccosanti [Italie] ; Francesca Colavita [Italie] ; Martina Di Rienzo [Italie] ; Concetta Castilletti [Italie] ; Maria Rosaria Capobianchi [Italie] ; Oliver Kepp [France] ; Laurence Zitvogel [France, République populaire de Chine] ; Gian Maria Fimia [Italie] ; Mauro Piacentini [Italie] ; Guido Kroemer [France, République populaire de Chine, Suède]	On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2.
001032 (2020)	Mohammed Noor Embi [Malaisie] ; Nagesswary Ganesan [Malaisie] ; Hasidah Mohd Sidek [Malaisie]	Is GSK3β a molecular target of chloroquine treatment against COVID-19?
001170 (2020)	Stephen J. Balevic ; Christoph P. Hornik ; Thomas P. Green ; Megan E B. Clowse ; Daniel Gonzalez ; Anil R. Maharaj ; Laura E. Schanberg ; Amanda M. Eudy ; Geeta K. Swamy ; Brenna L. Hughes ; Michael Cohen-Wolkowiez	Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials.
001267 (2020)	Ruochan Chen [République populaire de Chine] ; Yan Huang [République populaire de Chine] ; Jun Quan [République populaire de Chine] ; Jiao Liu [République populaire de Chine] ; Haichao Wang [États-Unis] ; Timothy R. Billiar [États-Unis] ; Michael T. Lotze [États-Unis] ; Herbert J. Zeh [États-Unis] ; Rui Kang [États-Unis] ; Daolin Tang [États-Unis]	HMGB1 as a potential biomarker and therapeutic target for severe COVID-19.
001317 (2020)	Ulf Norinder [Suède] ; Astrud Tuck [Suède] ; Kalle Norgren [Suède] ; Vesna Munic Kos [Suède]	Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19.
001455 (2020)	Aditi Banerjee [États-Unis] ; Steven J. Czinn [États-Unis] ; Russel J. Reiter [États-Unis] ; Thomas G. Blanchard [États-Unis]	Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19.
001524 (2020)	Meenakshisundaram Balasubramaniam [États-Unis] ; Robert J Shmookler Reis [États-Unis]	Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins.
001857 (2020)	Srinivasa Reddy Bonam [France] ; Sylviane Muller [France] ; Jagadeesh Bayry [France] ; Daniel J. Klionsky [États-Unis]	Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "target" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "target" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    target
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021